期刊文献+

抗GD2/抗CD16单链双特异性抗体的构建及在大肠杆菌中的表达 被引量:1

Construction and Expression of Anti-GD2/Anti-CD16 Single-chain Bispecific Antibody
下载PDF
导出
摘要 利用重叠PCR(overlap-PCR)将抗GD2表面抗原GD2的单链抗体基因m-ScFv和抗CD16的单链抗体基因NM3E2融合在一起,得到新型的单链双特异性抗体基因n-m,双抗的联接肽序列为SerGly4Ser,在肽连的C端引入了6×his以利于纯化。该双特异性抗体基因的序列经测序验证后,连接表达载体pET-22b(+),转化大肠杆菌菌株BL21(DE3),诱导表达,凝胶成像系统扫描显示表达的外源融合蛋白约占菌体总蛋白的27%。表达蛋白分泌于胞质空间,经超声波破胞后收集上清,经Ni+亲和层析柱分离,纯度可达90%以上。经SDS-PAGE及Westernblotting鉴定表达蛋白的分子量为53KD,与预期的相符。 This study sought to construct a recombinant vector that expresses anti-GD2/anti-CD16 bispecific single-chain antibody(sc-BsAb), and to assess its biological activities. The anti-GD2 gene and the anti-CD16 gene (NM3E2) were obtained using PCR amplification technique, and then the fusion gene was constructed by overlapping PCR. The sc-BsAb gene was subcloned into the pET-22b (±) plasmid from the pMD18-T easy vector by digestion with NcoI, Hind Ⅲ restriction endonucleases, whose sites exist in both the vectors. Then the combinant plasmids were transferred into E. coli BL21 (DE3). The expression product in the periplasmic was analyzed by both SDS-PAGE and Western blot technique, then was purified with Ni^2+-NTA superflow affinity chromatography. It was demonstrated that the linker in the sc-BsAb fusiori protein is SerGly4Ser. and the molecular is 53 KD.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2007年第3期659-663,共5页 Journal of Biomedical Engineering
关键词 单链抗体 单链双特异性抗体 表达 Single-chain antibody fragments (ScFv) Single-chain bispecific antibody (sc-BsAb) Expression
  • 相关文献

参考文献11

  • 1Ying C,Laura L.Bispecific antibody conjugates in therapeutics.Advanced Drug Delivery Reviews,2003;55:171-197
  • 2Louis M.Weiner,R.Katherine Alpaugh,et al.Margaret von Mehren Redirected cellular cytotoxicity employing bispecific antibodies and other multifunctional binding proteins.Cancer Immunology,Immunotherapy,1997;11:190-197
  • 3Bargou R,Loffler A,Kufer P,et al.Clinical application of a recombinant bispecific single chain antibody CD19×CD3 in patients with refractory B cell malignancies.Onkologie,1999;22:150
  • 4McCall AM,Adams GP,Amoroso AR,et al.Isolation and characterization of anti-CD16 single-chain Fv fragment and construction of anti-HER2/neu/anti-CD16 bispecific scfv that triggers CD16-dependent tumor cytolysis.Molecular Immunology,1999;36:433-445
  • 5孙静,吕安国,吴文芳,白向阳,任秀宝,张斌.噬菌体呈现技术筛选抗黑色素瘤单链抗体[J].天津医科大学学报,2003,9(2):219-222. 被引量:2
  • 6王鸿鹤,朱孝峰,谢冰芬,冯公侃,沈竞康,刘宗潮.人细胞周期蛋白D1及细胞周期蛋白激酶CDK4的原核表达及鉴定[J].中山大学学报(医学科学版),2003,24(5):444-447. 被引量:7
  • 7Korzeniewski C,Callewaert D M,et al.Anenzyme release assay for nature cytotoxicity.J Immunol Methods,1983;64(3):313
  • 8Cruber M,Schodin B A,Wilson E R,et al.Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.J Immunol,1994;17:5368
  • 9Holliger P,Prospero T,Winter G.'Diabodies'; small bivalent and bispecific antibody fragments.Proc Natl Acad Sci USA,1993;90:6444
  • 10Alt M,Muller R,Kontermann R E,et al.Novel tetralent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin gammal Fc or CH3 region.FEBS lett,1999;454:90

二级参考文献15

  • 1Testosi A, Mozzillo N.Surgical techniques of melanoma and sentinel node biopsy [J]. Semin Oncol, 2002,29(4) : 328.
  • 2Chowdhury PS. Improving antibody affinity by mimicking somatic hypermutation in vitro[J]. Nat Biotechnol, 1999, 17(6):568.
  • 3Jackson H, Bacon L, Pedley RB, et al. Antigen specificity and tumor targeting efficiency of human carcinoembryonic antigen-specific ScFv and affinity- matured derivatives[J] . Br J Cancer, 1998, 78(2) : 181.
  • 4Hoogenboom H, De - Beuine A, Hufton S, et al. Antibody phage display technology and its applications[J]. Immunotechnology, 1998,3(4) : 169.
  • 5Barbas CF 3rd, Kang AS, Lenner RA, et al. Assembly of combinatorial antibody libraries on phage surface: the gene Ⅲ site[J]. Proc Natl Acad Sci USA, 1991,89:10164.
  • 6Stillman B. Cell cycle control of DNA replication[J] .Science, 1996, 274(5293): 1659.
  • 7Buolamwini J K. Cell cycle molecular targets in novel anticancer drug discovery[J]. Curr Pharm Des, 2000, 6(4): 379.
  • 8Sherr C J. Cancer cell cycles[J] . Science, 1996, 274(5293): 1672.
  • 9David 0 M. Principles of CDK regulation[J]. Nature,1995, 374 (6518): 131.
  • 10Funk J O, Kino P. Cell cycle control, genetic instability Band cancer [J]. Hantarzt, 1997, 48 (3): 157.

共引文献7

同被引文献37

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部